Viewing Study NCT00536068


Ignite Creation Date: 2025-12-24 @ 5:42 PM
Ignite Modification Date: 2026-02-20 @ 1:45 PM
Study NCT ID: NCT00536068
Status: COMPLETED
Last Update Posted: 2007-09-28
First Post: 2007-09-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Platelet Inhibition by Aspirin, Acetaminophen and NSAID
Sponsor: Kantonsspital Graubünden
Organization:

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2007-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Nonsteroidal antiinflammatory drugs such as diclofenac or naproxen may interfere with the inhibition of platelet aggregation by aspirin, because they all interact with the platelet cyclooxygenase.This may be of great clinical importance because of an increased cardiovascular event rate (myocardial infarction, stroke). The present randomized, controlled study analyses in vitro platelet aggregation under a combined treatment of healthy volunteers with aspirin and either acetaminophen, diclofenac, naproxen, or placebo.
Detailed Description: An in vivo study on healthy volunteers with combinations of well established drugs

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: